{
    "url_original": "https://www.wsj.com/articles/pfizer-starts-testing-its-covid-19-pill-in-children-11646826300?mod=business_lead_pos4",
    "url": "pfizer-starts-testing-its-covid-19-pill-in-children-11646826300",
    "title": "Pfizer Starts Testing Its Covid-19 Pill in Children",
    "sub_head": "Drugmaker expects results from its study of Paxlovid in high-risk children by end of year",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2022-03-09 06:45:00",
    "body": "Pfizer Inc.  has begun studying its Covid-19 pill in children under 18 years old who are at high risk of developing severe disease.<br />The study will evaluate whether the five-day treatment Paxlovid, which is in use among people 12 years and older, can also keep children who are newly infected by the coronavirus out of the hospital, Pfizer said Wednesday."
}